XML 18 R2.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 10,009,217 $ 7,792,846
Marketable securities, current 35,082,502 0
Prepaid expenses and other current assets 2,236,436 1,256,501
Grant receivable 0 915,404
Total current assets 47,328,155 9,964,751
Marketable securities, non-current 5,806,260 0
Other assets 56,234 7,770
Total assets 53,190,649 9,972,521
Current liabilities:    
Accounts payable 725,854 662,471
Deferred grant revenue 1,401,501 0
Accrued expenses and other current liabilities 1,086,381 1,933,276
Total liabilities 3,213,736 2,595,747
Commitments and Contingencies  
Stockholders’ Equity:    
Common stock, $0.001 par value: 1,000,000,000 shares authorized: 8,253,741 and 5,674,520 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively 8,253 5,674
Additional paid-in capital 109,260,391 61,811,889
Accumulated other comprehensive loss (19,702) 0
Accumulated deficit (59,272,029) (54,440,789)
Total stockholders' equity 49,976,913 7,376,774
Total liabilities and stockholders' equity $ 53,190,649 $ 9,972,521